Emphysema is a type of chronic obstructive pulmonary disorder which involves damage to the air sacs (alveoli) in the lungs. It is a form of chronic lung disorder which causes difficulty in breathing. Emphysema is also called as obstructive disorder because airflow or exhalation is slow or stopped due to over inflammation of the alveoli. Emphysema results when thin membrane lining on the air sacs is damaged and is beyond repair. Thus, rupturing of air sacs leads to reduction in surface area of the lungs which in turn reduces the amount of oxygen reaching the blood stream. This is because damaged alveoli don’t work properly and old air is trapped inside the alveoli leaving no space for fresh air to enter in the sacs. Hence, lungs slowly enlarge and require more efforts for breathing. Shortness of breath, sputum production and productive cough are the major symptoms of emphysema. Similarly, difficulty in breathing while exercising might also be witnessed.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3454
Smoking is one of the major causes of emphysema among vast majority of population. As per the studies conducted smokers are six times more likely to be victim of emphysema as compared to non smokers. Apart from smoking alpha-1 antitrypsin (AAT) deficiency is another cause of emphysema. However, this is a minor cause of this medical condition as compared to smoking. AAT is a natural protein circulating in human blood whose function is to prevent white blood cells from destroying normal tissues. Deficiency of AAT is a genetic disorder due to which white blood cells continuously damage the normal tissues. Exact estimates are not known but it is stated that approximately 2% to 3% of people with emphysema have deficiency of AAT. Similarly, long time exposure to environmental cigarette smoking might also lead to the damage of risk of development of emphysema. Work place exposures are believed to be the cause in 10% to 20% of the cases.
Request COVID Analysis on Emphysema Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=3454
Currently, there is no cure for emphysema however; if smoking is quit then the symptoms of emphysema can be controlled. Thus, for diagnosis purpose spirometry test is prescribed to individuals who are aged above 30 years to 40 years. This medical device measures the amount of airflow obstruction present. Other tests such as chest X-ray and complete blood count are also useful test for the diagnosis of emphysema. For the treatment purpose bronchodialators, corticosteroids, oxygen medications and other antibiotics such as erythromycin are prescribed.
Request Customization on Emphysema Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=3454
According to the American Lung Association, COPD is currently the fourth leading cause of deaths in the United States. Similarly, According to World Health Organization (WHO) estimates, asthma affects nearly 300 million people worldwide, while COPD affects approximately 210 million people. The WHO further states that these numbers will continue increasing under the influence of factors such as increase in proportion of urban population, changing life style, growing number of tobacco smokers and rising pollution level.
Geographically, North America is the leading geography followed by the European market. Market growth of these regions is accounted due to the presence of large base of population suffering from COPD. Asia-Pacific and Rest of the world in the future are expected to emerge as the fastest growing economies in this market.
Pre Book Emphysema Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=3454<ype=S
Pulmonx , Bioxyne Limited, Intrexon Corporation, Icure Pharmaceuticals, Inc. Kamada Limited and others are the major players which have their therapeutic candidate in the pipeline for the treatment of emphysema.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
Natural Treatment for Emphysema is to stop more progression.
Home Remedies for Emphysema options that are very much important to people are discussed thoroughly.
Emphysema Market Research Report: By Type (Centrilobular, Panlobular), By Diagnosis (Imaging Test (X-Ray, Ct Scan), Lung Function Test), by Treatment (Medication (Antibiotics, Bronchodilators), Therapy, Surgery), by End-User-Global Forecast till 2027Market HighlightsFactors such as the increasing prevalence of the chronic obstructive pulmonary disease and the rising therapeutics’ demand are estimated to drive the market growth during the forecast period.
However, low awareness and lack of healthcare services in the middle- and low-income countries are estimated to restrain the market growth during the projected period.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5810SegmentationThe global emphysema market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of type, the market is segmented into centrilobular and panlobular emphysema.On the basis of diagnosis, the market is segmented into imaging tests, lung function tests, and others.
On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.Regional AnalysisThe Americas dominates the global emphysema market owing to the rising prevalence of the chronic obstructive pulmonary disease and presence of a well-developed healthcare sector within the region.
Moreover, the increasing healthcare expenditure and the presence of key players within the regional boundaries provide a favorable background for the market growth.
Factors such as increasing availability of funds for research and a huge patient population followed by a well-developed healthcare sector drive the market within the region.
This can be attributed to the presence of developing economies such as India and China and huge patient population.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the emphysema treatment market include Intrexon Corporation, Pulmonx Inc., Halozyme Therapeutics, Inc., Mariposa Health Limited, PneumRx, Uptake Medical Corporation, Icure Pharmaceuticals, Inc., Pfizer, Inc., BTG International’s, Olympus Corporation, Kamada Limited, Emphasys Medical, Inc., Bioxyne Limited.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Emphysema Treatment Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/emphysema-treatment-market/download-sampleMarket DynamicsThe rising number of COPD and the asthmatic population worldwide coupled with FDA consent for the novel products and its wide adoption among the patient are the major factors driving the emphysema treatment market over the forecast period.
Moreover, the high availability of diagnostic services for respiratory illness and rising government initiatives to control COPD and asthma are highly contributing to the global emphysema treatment markets growth.
The technological advancement in the treatment of asthma and COPD and rising pipeline products holds immense potential for the growth of the global emphysema treatment market.
Furthermore, increasing research and development in developing effective drugs with growing initiatives implemented by the non-government and government associations for creating health awareness are expected to create a lucrative opportunity for the key players in the coming years.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
The global Emphysema market is rising continually, mainly due to the rising prevalence of the condition.
The market appears well-developed due to the availability of many novel treatments and therapeutics.
Also, there are various capable medical devices available in the market for the diagnosis and treatment of Emphysema.
Rising cases of respiratory diseases such as chronic bronchitis and COPD drive the growth of the market, predominantly.
Global Emphysema Market – SegmentsThe report is segmented into five market dynamics to widen the scope of understanding,By Type: Centrilobular and Panlobular Emphysema.By Diagnosis: Imaging Test (X-Ray, CT scan) and Lung Function Test, among others.By Treatment: Medication (Antibiotics, Bronchodilators, others), Therapy, and Surgery, among others.By End-user: Hospitals & Clinics and Surgical Centers, among others.By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.Global Emphysema Market – Regional AnalysisNorth America leads the global Emphysema market due to the increasing prevalence of the condition.
The presence of well-developed healthcare sectors and several major players, alongside, the high healthcare spending fosters the growth of the market.
